Terms: = Breast cancer AND FAT4, ENSG00000196159, 79633
12 results:
1. Genomic alteration profile and PD-L1 expression among different breast cancer subtypes in Chinese population and their correlations.
Li K; Cao L; Li C; Wu J; Chen B; Zhang G; Li X; Wen L; Jia M; Wei G; Lin J; Li Y; Zhang Y; Mok H; Ren C; Wang Y; Qi X; Guo L; Che Y; Liao N
Cancer Med; 2023 Mar; 12(5):5195-5208. PubMed ID: 36404592
[TBL] [Abstract] [Full Text] [Related]
2. A pan-cancer analysis of FAT atypical cadherin 4 (fat4) in human tumors.
Mao W; Zhou J; Hu J; Zhao K; Fu Z; Wang J; Mao K
Front Public Health; 2022; 10():969070. PubMed ID: 36051999
[TBL] [Abstract] [Full Text] [Related]
3. American Joint Committee on cancer Tumor Staging System Predicts the Outcome and Metastasis Pattern in Conjunctival Melanoma.
Jia S; Zhu T; Shi H; Zong C; Bao Y; Wen X; Ge S; Ruan J; Xu S; Jia R; Fan X
Ophthalmology; 2022 Jul; 129(7):771-780. PubMed ID: 35245602
[TBL] [Abstract] [Full Text] [Related]
4. Systemic analysis of the expression levels and prognosis of breast cancer-related cadherins.
Xu M; Liu C; Pu L; Lai J; Li J; Ning Q; Liu X; Deng S
Exp Biol Med (Maywood); 2021 Aug; 246(15):1706-1720. PubMed ID: 33899544
[TBL] [Abstract] [Full Text] [Related]
5. Massively parallel sequencing analysis of benign melanocytic naevi.
Lozada JR; Geyer FC; Selenica P; Brown D; Alemar B; Merghoub T; Berger MF; Busam KJ; Halpern AC; Weigelt B; Reis-Filho JS; Hollmann TJ
Histopathology; 2019 Jul; 75(1):29-38. PubMed ID: 30791119
[TBL] [Abstract] [Full Text] [Related]
6. Down-regulated long non-coding RNA RNAZFHX4-AS1 suppresses invasion and migration of breast cancer cells via fat4-dependent Hippo signaling pathway.
Li SY; Wang H; Mai HF; Li GF; Chen SJ; Li GS; Liang BC
Cancer Gene Ther; 2019 Nov; 26(11-12):374-387. PubMed ID: 30546116
[TBL] [Abstract] [Full Text] [Related]
7. Relationship Between DNA Methylation in Key Region and the Differential Expressions of Genes in Human breast Tumor Tissue.
Jin W; Li QZ; Zuo YC; Cao YN; Zhang LQ; Hou R; Su WX
DNA Cell Biol; 2019 Jan; 38(1):49-62. PubMed ID: 30346835
[TBL] [Abstract] [Full Text] [Related]
8. Evaluation of a developmental hierarchy for breast cancer cells to assess risk-based patient selection for targeted treatment.
Bliss SA; Paul S; Pobiarzyn PW; Ayer S; Sinha G; Pant S; Hilton H; Sharma N; Cunha MF; Engelberth DJ; Greco SJ; Bryan M; Kucia MJ; Kakar SS; Ratajczak MZ; Rameshwar P
Sci Rep; 2018 Jan; 8(1):367. PubMed ID: 29321622
[TBL] [Abstract] [Full Text] [Related]
9. ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breast.
Ping Z; Siegal GP; Harada S; Eltoum IE; Youssef M; Shen T; He J; Huang Y; Chen D; Li Y; Bland KI; Chang HR; Shen D
Oncotarget; 2016 Dec; 7(49):80655-80663. PubMed ID: 27811364
[TBL] [Abstract] [Full Text] [Related]
10. Function and cancer genomics of FAT family genes (review).
Katoh M
Int J Oncol; 2012 Dec; 41(6):1913-8. PubMed ID: 23076869
[TBL] [Abstract] [Full Text] [Related]
11. Identification of fat4 as a candidate tumor suppressor gene in breast cancers.
Qi C; Zhu YT; Hu L; Zhu YJ
Int J Cancer; 2009 Feb; 124(4):793-8. PubMed ID: 19048595
[TBL] [Abstract] [Full Text] [Related]
12. Comparative integromics on FAT1, FAT2, FAT3 and fat4.
Katoh Y; Katoh M
Int J Mol Med; 2006 Sep; 18(3):523-8. PubMed ID: 16865240
[TBL] [Abstract] [Full Text] [Related]
